Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.26
+0.06 (1.15%)
Apr 14, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Pharmaceuticals
61.86M56.13M79.18M73.67M63.13M
Pharmaceuticals Growth
10.20%-29.11%7.48%16.69%41.78%
Total
61.86M56.13M79.18M73.67M63.13M
Total Growth
10.20%-29.11%7.48%16.69%41.78%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
61.86M56.13M79.18M73.67M63.13M
United States Growth
10.20%-29.11%7.48%16.69%41.78%
Total
61.86M56.13M79.18M73.67M63.13M
Total Growth
10.20%-29.11%7.48%16.69%41.78%
Source: S&P Global Market Intelligence.